RADICAVA
Google image searchProduct monograph
Active ingredient
edaravone, 105 MG/5 ML
DIN: 02532611
Dosage form(s): SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: MITSUBISHI TANABE PHARMA CORPORATION
Date: 09-FEB-2023
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07X — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD)
- N07XX — Other nervous system drugs (ATC, ATC/DDD)
- N07XX14 — EDARAVONE (ATC/DDD)
